Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice

被引:12
|
作者
Pan, Xian [2 ]
Kent, Rebecca [2 ]
Won, Kyoung-Jae [1 ]
Jeong, Hyunyoung [1 ,2 ]
机构
[1] Univ Illinois, Coll Pharm, Dept Pharm Practice, 900 South Ashland Ave,MC 870, Chicago, IL 60607 USA
[2] Univ Illinois, Coll Pharm, Dept Biopharmaceut Sci, 900 South Ashland Ave,MC 870, Chicago, IL 60607 USA
基金
美国国家卫生研究院;
关键词
SMALL HETERODIMER PARTNER; BACTERIAL TRANSLOCATION; INDUCED CHOLESTASIS; IN-VIVO; BILE; LIVER; SHP; METABOLISM; REPRESSION; BIOSYNTHESIS;
D O I
10.1124/dmd.116.074013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 2D6 (CYP2D6) is a major drug-metabolizing enzyme, but the factors governing transcriptional regulation of its expression remain poorly understood. Based on previous reports of small heterodimer partner (SHP) playing an important role as a transcriptional repressor of CYP2D6 expression, here we investigated how a known upstream regulator of SHP expression, namely cholestasis triggered by cholic acid (CA) feeding in mice, can lead to altered CYP2D6 expression. To this end, CYP2D6-humanized (Tg-CYP2D6) mice were fed with a CA-supplemented or control diet for 14 days, and hepatic expression of multiple genes was examined. Unexpectedly, CA feeding led to insignificant changes in SHP mRNA but also to significant (2.8-fold) decreases in SHP protein levels. In silico analysis of the SHP gene regulatory region revealed a putative binding site for a microRNA, miR-142-3p. Results from luciferase reporter assays suggest that miR-142-3p targets the SHP gene. Hepatic expression of miR-142-3p was significantly increased in CA-fed mice (similar to 5-fold), suggesting a potential role of miR-142-3p in the regulation of SHP expression in cholestasis. The decreased SHP protein levels were accompanied by increased expression and activity of CYP2D6 in the liver of CA-fed mice. These results suggest potential roles of differential hepatic levels of bile acids in the transcriptional regulation of CYP2D6 expression.
引用
收藏
页码:346 / 352
页数:7
相关论文
共 50 条
  • [41] The interaction of terfenadine with CYP2D6
    Jones, BC
    Hyland, R
    Ackland, M
    Tyman, CA
    Smith, DA
    [J]. FASEB JOURNAL, 2000, 14 (08): : A1503 - A1503
  • [42] The CYP2D6 VCF Translator
    Qiao, W.
    Wang, J.
    Pullman, B. S.
    Chen, R.
    Yang, Y.
    Scott, S. A.
    [J]. PHARMACOGENOMICS JOURNAL, 2017, 17 (04): : 301 - 303
  • [43] Understanding CYP2D6 interactions
    de Groot, Marcel J.
    Wakenhut, Florian
    Whitlock, Gavin
    Hyland, Ruth
    [J]. DRUG DISCOVERY TODAY, 2009, 14 (19-20) : 964 - 972
  • [44] The CYP2D6 VCF Translator
    W Qiao
    J Wang
    B S Pullman
    R Chen
    Y Yang
    S A Scott
    [J]. The Pharmacogenomics Journal, 2017, 17 : 301 - 303
  • [45] CYP2D6, serotonin and suicide
    Ahlner, Johan
    Zackrisson, Anna-Lena
    Lindblom, Bertil
    Bertilsson, Leif
    [J]. PHARMACOGENOMICS, 2010, 11 (07) : 903 - 905
  • [46] CYP2D6 genotyping and codeine
    De Leon, Jose
    [J]. PEDIATRIC ANESTHESIA, 2008, 18 (03) : 274 - 275
  • [47] CYP2D6 phenotyping with dextromethorphan
    Wojtczak, Anna
    Rychlik-Sych, Mariola
    Krochmalska-Ulacha, Eliza
    Skretkowicz, Jadwiga
    [J]. PHARMACOLOGICAL REPORTS, 2007, 59 (06) : 734 - 738
  • [48] PharmVar GeneFocus: CYP2D6
    Nofziger, Charity
    Turner, Amy J.
    Sangkuhl, Katrin
    Whirl-Carrillo, Michelle
    Agundez, Jose A. G.
    Black, John L.
    Dunnenberger, Henry M.
    Ruano, Gualberto
    Kennedy, Martin A.
    Phillips, Michael S.
    Hachad, Houda
    Klein, Teri E.
    Gaedigk, Andrea
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (01) : 154 - 170
  • [49] Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity
    Dalton, Rachel
    Lee, Seung-been
    Claw, Katrina G.
    Prasad, Bhagwat
    Phillips, Brian R.
    Shen, Danny D.
    Wong, Lai Hong
    Fade, Mitch
    McDonald, Matthew G.
    Dunham, Maitreya J.
    Fowler, Douglas M.
    Rettie, Allan E.
    Schuetz, Erin
    Thornton, Timothy A.
    Nickerson, Deborah A.
    Gaedigk, Andrea
    Thummel, Kenneth E.
    Woodahl, Erica L.
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (01): : 147 - 156
  • [50] MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers
    de la Torre, R
    Farré, M
    Mathúna, BO
    Roset, PN
    Pizarro, N
    Segura, M
    Torrens, M
    Ortuño, J
    Pujadas, M
    Camí, J
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (07) : 551 - 554